Understanding Lewy Body Dementia: A Deep Dive

Lewy body dementia (LBD) is a progressive brain disorder caused by abnormal clumps of a protein called alpha-synuclein, known as Lewy bodies, accumulating within brain neurons. Named after Dr. Friedrich Lewy, who identified them in 1912, these protein deposits interfere with normal brain function and are associated with the loss of neurons that produce key neurotransmitters like acetylcholine, vital for memory and learning, and dopamine, which regulates movement, thinking, and mood.

Over 7 million Americans have been diagnosed with dementia, a condition that gradually impairs memory, thinking skills, and the ability to perform daily tasks. Alzheimer's disease accounts for approximately 60% to 70% of dementia cases, while LBD is responsible for about 10% to 15%.

LBD is distinct from Alzheimer's, which is primarily characterized by beta-amyloid plaques and tau tangles. Dr. Jonathan Fellows of the Michigan Institute for Neurological Disorders (MIND) explains that LBD has core clinical features differentiating it from Alzheimer's, including fluctuations in cognition, alertness, and attention that can vary significantly over short periods. While individuals with Alzheimer's often struggle with forming new memories, those with LBD may form new memories but have difficulty retrieving them.

LBD does not have formal stages like Alzheimer's, but it presents with distinct symptoms. A notable sign is the "Lewy lean," described as gait and balance problems that can manifest as a persistent lean while sitting, standing, or walking, difficulty maintaining an upright posture, challenges walking straight, and increased falls due to loss of balance. Patients may also experience vivid visual hallucinations and sleep disturbances early in the disease process. REM sleep behavior disorder, where individuals act out their dreams, often precedes cognitive symptoms by many years.

The exact cause of LBD remains unknown, but researchers suspect a combination of genetic, environmental, and lifestyle factors. While not typically considered hereditary, certain genetic variants have been linked to an increased risk.

There is no cure for LBD, and treatment focuses on managing symptoms. Therapies often overlap with those for Alzheimer's and Parkinson's disease. Cholinesterase inhibitors, such as rivastigmine or donepezil, can help with cognition, attention, and hallucinations, though they are not FDA-approved for LBD. Levodopa therapy, like Sinemet, may manage Parkinson's-like symptoms. Atypical antipsychotic medications are used for hallucinations, delusions, and agitation, but traditional antipsychotics should be avoided as they can worsen LBD symptoms. Melatonin or clonazepam can be used to treat REM sleep behavior disorder.

Several public figures have battled LBD, including actor Robin Williams, radio personality Casey Kasem, "Golden Girls" star Estelle Getty, musician Glen Campbell, and baseball pitcher Tom Seaver.